Literature DB >> 23401270

Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?

Morris Sherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23401270     DOI： 10.1002/hep.26317

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.

Authors:  Stuart C Gordon; Lois E Lamerato; Loralee B Rupp; Jia Li; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Vinutha Vijayadeva; Joseph A Boscarino; Emily M Henkle; Nancy Oja-Tebbe; Mei Lu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-06       Impact factor: 11.382

Review 2.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.